# AMGEN INC: Form D filings

AMGEN INC, a biotechnology company in Thousand Oaks, CA, filed 5 Form D notices with the SEC between 2011 and 2015. The latest, on January 23, 2015, reports an offering of $2.50 billion with nothing sold yet to 34 investors.

Find out what AMGEN INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20AMGEN%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=AMGEN%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Famgen-inc-318154)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20AMGEN%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=AMGEN%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Famgen-inc-318154)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: One Amgen Center Drive, Thousand Oaks, CA, 91320
- Phone: (805) 447-1000
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 318154

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 23, 2015 | Amendment | $2,500,000,000 | $0 | $2,500,000,000 | 34 | Sep 28, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/318154/000120919115006171/0001209191-15-006171-index.htm) |
| Jan 29, 2014 | Amendment | $2,500,000,000 | $0 | $2,500,000,000 | 34 | Sep 28, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/318154/000120919114005573/0001209191-14-005573-index.htm) |
| Feb 4, 2013 | Amendment | $2,500,000,000 | $0 | $2,500,000,000 | 34 | Sep 28, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/318154/000120919113006100/0001209191-13-006100-index.htm) |
| Feb 29, 2012 | Amendment | $2,500,000,000 | $0 | $2,500,000,000 | 34 | Sep 28, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/318154/000118143112012945/0001181431-12-012945-index.htm) |
| Mar 14, 2011 | New notice | $2,322,500,000 | $0 | $2,322,500,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/318154/000118143111017574/0001181431-11-017574-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| David M. Piacquad | Executive Officer |  |
| Francois J. de Carbonnel | Director |  |
| Brian M. McNamee | Executive Officer |  |
| Tyler C. Jacks | Director |  |
| Ronald D. Sugar | Director |  |
| Robert A. Bradway | Executive Officer, Director |  |
| David J. Scott | Executive Officer |  |
| Madhavan A. Balachandran | Executive Officer |  |
| Stuart A. Tross | Executive Officer |  |
| David W. Meline | Executive Officer |  |
| Sean E. Harper | Executive Officer |  |
| Rebecca M. Henderson | Director |  |
| Judith C. Pelham | Director |  |
| Vance D. Coffman | Director |  |
| David A. Baltimore | Director |  |
| Cynthia M. Patton | Executive Officer |  |
| Greg C. Garland | Director |  |
| Frank C. Herringer | Director |  |
| Frank J. Biondi, Jr. | Director |  |
| Robert A. Eckert | Director |  |
| Anthony C. Hooper | Executive Officer |  |
| R. Sanders Williams | Director |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026
- [Estuary Biotherapeutics, Inc.](https://specstream.ai/data/form-d/company/estuary-biotherapeutics-inc-2138862) $40.7 million · Oct 16, 2026
- [Renue Life Sciences, Inc.](https://specstream.ai/data/form-d/company/renue-life-sciences-inc-2158207) $250,000 · Oct 14, 2026
- [Tempest Therapeutics, Inc.](https://specstream.ai/data/form-d/company/tempest-therapeutics-inc-1544227) $7.5 million · Oct 14, 2026
- [Lionheart Health, Inc.](https://specstream.ai/data/form-d/company/lionheart-health-inc-2156758) $387,500 · Oct 7, 2026
- [Rakuten Medical, Inc.](https://specstream.ai/data/form-d/company/rakuten-medical-inc-1595215) $9 million · Oct 6, 2026
- [Zonaliz, Inc.](https://specstream.ai/data/form-d/company/zonaliz-inc-2157556) $2.5 million · Oct 5, 2026
- [Altay Therapeutics, Inc.](https://specstream.ai/data/form-d/company/altay-therapeutics-inc-2157551) $15.7 million · Oct 2, 2026
- [Sialia Therapeutics, Inc.](https://specstream.ai/data/form-d/company/sialia-therapeutics-inc-2156754) $1.5 million · Sep 29, 2026
- [Vetmab Biosciences, Inc.](https://specstream.ai/data/form-d/company/vetmab-biosciences-inc-1932050) $11.4 million · Sep 29, 2026

[Every Form D from the week of Jan 19, 2015](https://specstream.ai/data/form-d/week/2015-01-19) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what AMGEN INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).